NASDAQ:CWBR

CohBar Stock Forecast, Price & News

$1.37
-0.08 (-5.52 %)
(As of 04/9/2021 07:42 PM ET)
Add
Compare
Today's Range
$1.37
Now: $1.37
$1.49
50-Day Range
$1.26
MA: $1.48
$1.93
52-Week Range
$0.85
Now: $1.37
$4.25
Volume610,300 shs
Average Volume697,972 shs
Market Capitalization$84.65 million
P/E RatioN/A
Dividend YieldN/A
Beta2.96
CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes mellitus, cancer, atherosclerosis, cardiovascular, and neurodegenerative diseases, such as Alzheimer's disease. Its lead MBT candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial-derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases, CB5064 analogs for COVID-19 associated ARDS, MBT5 analogs for CXCR4-related cancer and orphan diseases, and MBT3 analogs for cancer immunotherapy. The company was founded in 2007 and is headquartered in Menlo Park, California.
CohBar logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CWBR
CUSIPN/A
CIKN/A
Phone650 446 7888
Employees12
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.19 per share

Profitability

Net Income$-13,050,000.00

Miscellaneous

Market Cap$84.65 million
Next Earnings Date5/13/2021 (Estimated)
OptionableNot Optionable

Headlines

CohBar (NASDAQ:CWBR) Earns "Buy" Rating from Aegis
April 6, 2021 |  americanbankingnews.com
CohBar (NASDAQ:CWBR) PT Raised to $3.50
March 31, 2021 |  americanbankingnews.com
CohBar (CWBR) Set to Announce Quarterly Earnings on Tuesday
March 23, 2021 |  americanbankingnews.com
Aegis Initiates Coverage on CohBar (NASDAQ:CWBR)
March 22, 2021 |  americanbankingnews.com
CohBar (NASDAQ:CWBR) Shares Down 8.5%
March 18, 2021 |  americanbankingnews.com
See More Headlines

MarketRank

Overall MarketRank

1.53 out of 5 stars

Medical Sector

477th out of 2,011 stocks

Pharmaceutical Preparations Industry

231st out of 772 stocks

Analyst Opinion: 3.5Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$1.37
-0.08 (-5.52 %)
(As of 04/9/2021 07:42 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CWBR News and Ratings via Email

Sign-up to receive the latest news and ratings for CWBR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CohBar (NASDAQ:CWBR) Frequently Asked Questions

Is CohBar a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CohBar in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CohBar stock.
View analyst ratings for CohBar
or view top-rated stocks.

What stocks does MarketBeat like better than CohBar?

Wall Street analysts have given CohBar a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CohBar wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is CohBar's next earnings date?

CohBar is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for CohBar
.

How were CohBar's earnings last quarter?

CohBar, Inc. (NASDAQ:CWBR) posted its quarterly earnings data on Monday, March, 29th. The company reported ($0.08) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.02.
View CohBar's earnings history
.

How has CohBar's stock price been impacted by Coronavirus?

CohBar's stock was trading at $1.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CWBR shares have decreased by 22.2% and is now trading at $1.37.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for CWBR?

5 Wall Street analysts have issued 1-year price targets for CohBar's stock. Their forecasts range from $3.50 to $8.00. On average, they expect CohBar's stock price to reach $5.50 in the next year. This suggests a possible upside of 301.5% from the stock's current price.
View analysts' price targets for CohBar
or view top-rated stocks among Wall Street analysts.

Who are CohBar's key executives?

CohBar's management team includes the following people:
  • Mr. Steven B. Engle M.S., CEO & Director (Age 66, Pay $424.73k)
  • Dr. Pinchas Cohen, Co-Founder & Independent Director (Age 64, Pay $64.12k)
  • Dr. Nir Yacov Barzilai, Co-Founder & Independent Director (Age 65, Pay $64.12k)
  • Mr. Jeffrey F. Biunno CPA, M.B.A., CPA, MBA, CFO, Treasurer & Sec. (Age 55, Pay $317.68k)
  • Dr. Kenneth C. Cundy, Chief Scientific Officer (Age 62, Pay $383.27k)
  • Dr. David Andrew Sinclair A.O., Ph.D., Co-Founder, Advisor & Consultant (Age 51)
  • Ms. Jordyn Tarazi, Director of Investor Relations
  • Dr. Changhan David Lee Ph.D., Consultant of Mitochondrial Biology
  • Dr. Rohit Loomba, Scientific Consultant

Who are some of CohBar's key competitors?

What other stocks do shareholders of CohBar own?

What is CohBar's stock symbol?

CohBar trades on the NASDAQ under the ticker symbol "CWBR."

How do I buy shares of CohBar?

Shares of CWBR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CohBar's stock price today?

One share of CWBR stock can currently be purchased for approximately $1.37.

How much money does CohBar make?

CohBar has a market capitalization of $84.65 million. The company earns $-13,050,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis.

How many employees does CohBar have?

CohBar employs 12 workers across the globe.

What is CohBar's official website?

The official website for CohBar is www.cohbar.com.

Where are CohBar's headquarters?

CohBar is headquartered at 1455 Adams Drive Suite 2050, Menlo Park CA, 94025.

How can I contact CohBar?

CohBar's mailing address is 1455 Adams Drive Suite 2050, Menlo Park CA, 94025. The company can be reached via phone at 650 446 7888 or via email at [email protected]


This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.